Association between pharmacist-led medication review and post-operative delirium: evidence from rural primary-care patients
Published
July 25, 2026
Paper ID
PAP-000281
Status
Published
DOI
10.65712/tmj.test000539
Advance Services
Abstract
Background: The cost of post-operative delirium to health systems is substantial. Methods: We conducted a randomised controlled trial across 7 centres between 2017 and 2022. Results: post-operative delirium occurred in 7% of the intervention group versus 20% of controls. The adjusted odds ratio was 0.60 (95% CI 0.41 to 0.69). Conclusion: These findings suggest that pharmacist-led medication review is associated with better post-operative delirium in rural primary-care patients.
Introduction
post-operative delirium remains a leading cause of avoidable harm among rural primary-care patients. Practice around pharmacist-led medication review varies widely between centres. Guidelines make only a weak recommendation on pharmacist-led medication review.
post-operative delirium remains a leading cause of avoidable harm among rural primary-care patients.
The cost of post-operative delirium to health systems is substantial. post-operative delirium remains a leading cause of avoidable harm among rural primary-care patients.
Discussion
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded. Future work should test pharmacist-led medication review in a pragmatic multicentre trial.
Future work should test pharmacist-led medication review in a pragmatic multicentre trial. These findings suggest that pharmacist-led medication review is associated with better post-operative delirium in rural primary-care patients. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. These findings suggest that pharmacist-led medication review is associated with better post-operative delirium in rural primary-care patients.
Conclusions
Pharmacist-led medication review may be offered for rural primary-care patients to improve post-operative delirium.
References
1. Dubois S, Dubois L, et al. Prone positioning and patient satisfaction. BMJ. 2015;89(3):28-1189.
2. Rossi A, Kaur L, et al. Low-dose aspirin and post-operative delirium. Crit Care Med. 2025;348(7):882-1077.
3. Rahman M, Nasser A, et al. Low-dose aspirin and health-related quality of life. N Engl J Med. 2015;77(5):437-1192.
4. Mueller O, Schmidt O, et al. Vitamin D supplementation and glycaemic control. Pediatrics. 2016;73(4):329-978.
5. Lindqvist P, Silva X, et al. A sepsis alert system and time to diagnosis. Crit Care Med. 2015;363(2):70-1613.
6. Osei U, Mueller G, et al. Low-dose aspirin and surgical site infection. Crit Care Med. 2025;333(5):524-924.
7. Ahmed A, Osei K, et al. Vitamin D supplementation and medication adherence. Pediatrics. 2020;364(11):552-1155.
8. Osei D, Silva T, et al. Delayed cord clamping and in-hospital mortality. Diabetes Care. 2020;10(8):591-1123.
Appendices
Ethics approval: IRB-9864.
Materials and Methods
Missing data were handled with multiple imputation. We conducted a randomised controlled trial across 6 centres between 2019 and 2025. We conducted a randomised controlled trial across 5 centres between 2019 and 2023. We conducted a randomised controlled trial across 4 centres between 2019 and 2022.
Missing data were handled with multiple imputation. Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. 4023 participants were included (median age 68 years).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Centre A | 889 | 113 | 38.7 | 0.72 | 0.40–1.33 |
| Male | 761 | 92 | 20.8 | 0.87 | 0.51–1.34 |
| Intervention | 625 | 3 | 29.0 | 0.50 | 0.60–1.4 |
Values are n (%) unless stated otherwise.

Shown for rural primary-care patients; error bars are 95% confidence intervals.

Shown for rural primary-care patients; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. 2319 participants were included (median age 39 years).
Effects were consistent across prespecified subgroups. post-operative delirium occurred in 14% of the intervention group versus 14% of controls.